Teva partners with Israeli institutes for early-stage drug research

France Nouvelles Nouvelles

Teva partners with Israeli institutes for early-stage drug research
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

Teva Pharmaceutical Industries on Monday signed research agreements with two lea...

FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File Photo

JERUSALEM - Teva Pharmaceutical Industries on Monday signed research agreements with two leading Israeli academic institutes, a move to boost its early-stage drug development with a focus on cancer treatments. The world’s largest generic drugmaker has been looking to expand its specialty portfolio and said it is seeking more than 400 new laboratories within Israeli academia.

A partnership with Tel Aviv University will focus on research and development in cancer and brain studies, while a collaboration with the Weizmann Institute of Science will try to identify antibodies for cancer treatment, Israel-based Teva said. “Teva is planning to carry out much more cutting-edge collaboration with researchers from leading universities and medical centers in Israel in the fields of oncology, immunology and brain studies - areas in which Israel has unique research capabilities,” said Steffen Nock, head of Teva’s innovative research team.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Product Hunt Founder Ryan Hoover Raises $10 Million Second Fund For More Early-Stage ExperimentsProduct Hunt Founder Ryan Hoover Raises $10 Million Second Fund For More Early-Stage ExperimentsTwo years after launching the Weekend Fund, Product Hunt founder Ryan Hoover is back with a $10 million second fund to invest in -- and help create -- more early-stage entrepreneurs.
Lire la suite »

Many stem cell clinics promise unapproved treatments: How to stay safeMany stem cell clinics promise unapproved treatments: How to stay safeStem cells hold a lot of promise, but much more research is needed.
Lire la suite »

SpaceX's Starlink satellites are already messing with astronomical research but there are thousands more plannedSpaceX's Starlink satellites are already messing with astronomical research but there are thousands more plannedAstronomers warned that SpaceX's Starlink satellites could majorly jeopardise astronomical research.
Lire la suite »

U.S. Mayo Clinic partners with Abu Dhabi to operate hospitalU.S. Mayo Clinic partners with Abu Dhabi to operate hospitalAbu Dhabi has partnered with U.S. non-profit organization Mayo Clinic in a joint...
Lire la suite »

Merkel ally calls for better Franco-German ties after NATO rowMerkel ally calls for better Franco-German ties after NATO rowGermany and France must bury their differences and pursue a constructive partner...
Lire la suite »



Render Time: 2025-04-06 04:06:33